Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-03-01 (Winlevi) cream in facial acne vulgaris
NCT01631474Phase 2Completed
- Sponsor
- Intrepid Therapeutics, Inc.
- Start
- Jun 2012
- Primary completion
- Feb 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of clascoterone in acne vulgaris, sponsored by Intrepid Therapeutics, Inc.. Started Jun 2012; status: completed.
02
Drugs
clascoterone
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT01631474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01631474.